GXMC
EGRX

Global X Management Company’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Global X Management Company’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-352
Closed -$19K – 1199
2018
Q1 		$19K Buy
352
+88
+33% +$5.12K ﹤0.01% 1117
2017
Q4 		$14K Buy
264
+61
+30% +$3.4K ﹤0.01% 1039
2017
Q3 		$12K Buy
203
+29
+17% +$1.75K ﹤0.01% 1096
2017
Q2 		$14K Buy
174
+45
+35% +$3.68K ﹤0.01% 1194
2017
Q1 		$11K Buy
129
+5
+4% +$372 ﹤0.01% 1139
2016
Q4 		$10K Buy
124
+2
+2% +$145 ﹤0.01% 1037
2016
Q3 		$9K Hold
122
– – ﹤0.01% 1025
2016
Q2 		$5K Buy
+122
New +$5.08K ﹤0.01% 934

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Global X Management Company's EGRX Position: Q2 2018 in Review

Global X Management Company sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2018, closing a stake of 352 shares — an estimated $19K sold.

Global X Management Company first reported a position in EGRX in Q2 2016 and held it in 8 quarters. The position peaked at $19K in Q1 2018. 183 funds tracked by Wall St. Rank hold EGRX as of Q2 2018.

  • Global X Management Company reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Global X Management Company sold 352 Eagle Pharmaceuticals, Inc. shares in Q2 2018, an estimated $19K.
  • Global X Management Company first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2016 and held it in 8 quarters.
  • Global X Management Company's Eagle Pharmaceuticals, Inc. position peaked at $19K in Q1 2018.
  • 183 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.